- Home
- SGMT vs OGI Comparison
SGMT vs OGI Comparison
Compare SGMT & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- OGI
- Stock Information
- Founded
- SGMT 2006
- OGI 2013
- Country
- SGMT United States
- OGI Canada
- Employees
- SGMT N/A
- OGI N/A
- Industry
- SGMT
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- SGMT
- OGI Health Care
- Exchange
- SGMT Nasdaq
- OGI Nasdaq
- Market Cap
- SGMT 238.7M
- OGI 234.5M
- IPO Year
- SGMT 2023
- OGI N/A
- Fundamental
- Price
- SGMT $8.30
- OGI $1.62
- Analyst Decision
- SGMT Strong Buy
- OGI
- Analyst Count
- SGMT 8
- OGI 0
- Target Price
- SGMT $26.88
- OGI N/A
- AVG Volume (30 Days)
- SGMT 651.1K
- OGI 565.8K
- Earning Date
- SGMT 11-13-2025
- OGI 12-17-2025
- Dividend Yield
- SGMT N/A
- OGI N/A
- EPS Growth
- SGMT N/A
- OGI N/A
- EPS
- SGMT N/A
- OGI 0.05
- Revenue
- SGMT N/A
- OGI $164,107,753.00
- Revenue This Year
- SGMT N/A
- OGI $59.31
- Revenue Next Year
- SGMT N/A
- OGI $15.12
- P/E Ratio
- SGMT N/A
- OGI $31.67
- Revenue Growth
- SGMT N/A
- OGI 50.01
- 52 Week Low
- SGMT $1.73
- OGI $0.85
- 52 Week High
- SGMT $11.41
- OGI $2.08
- Technical
- Relative Strength Index (RSI)
- SGMT 54.70
- OGI 38.63
- Support Level
- SGMT $8.02
- OGI $1.67
- Resistance Level
- SGMT $9.46
- OGI $1.79
- Average True Range (ATR)
- SGMT 0.62
- OGI 0.08
- MACD
- SGMT 0.07
- OGI -0.04
- Stochastic Oscillator
- SGMT 45.67
- OGI 3.37
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.